NEW YORK (GenomeWeb) – GenDx has obtained CE-IVD certification for its entire AlleleSEQR product line for human leukocyte antigen (HLA) typing.

AlleleSEQR uses PCR amplification and Sanger sequencing to test for several types of HLA genes that are involved in immune response and have bearing on stem cell or organ transplant success or rejection. There are test kits for HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.